James L. Kempner
Mr. Kempner is President of LSH Partners. Prior to LSH Partners, Mr. Kempner was President of Loeb Partners Corporation from 2014 to 2016.
Mr. Kempner began his career at Lazard, in 1983 and was named a General Partner in 1993. Mr. Kempner was involved in banking and capital markets transactions and managed Lazard’s Corporate Finance department from 1995-1998 and founded Lazard’s Logistics and Transportation group in 2000. His most recent role was as Senior Advisor in Lazard’s general industrials banking group, with emphasis on companies in the Transportation and Logistics industries. Mr. Kempner also served on the Underwriting and Private Placement Committees of Lazard. While at Lazard, Mr. Kempner advised Cardinal Logistics on its sale to Centerbridge, General Maritime on its restructuring, Box Ships on its Initial Public Offering, Atlantic Street Capital on its sale of Fleetgistics, the Special Committee of Overseas America on its sale to OSG, ITS Technologies & Logistics on its sale to The Carlyle Group, New Breed on its sale to Warburg, Pincus, Navios Maritime on its sale to International Shipping Enterprises, SuperValu on its acquisition and sale of Total Logistics, and advised UTI on its Initial Public Offering.
Outside of the Logistics and Transportation Industry, Mr. Kempner advised Intersections Inc. (NASDAQ=INTX) on its Initial Public Offering, MasterCraft on its sale to TRP and Charlesbank, and FuelCell Energy (NASDAQ=FCEL) on its acquisition of Global Thermoelectric. While at LSH, Mr. Kempner has advised Pharmachem Laboratories on its sale to Ashland, VSS SC III on its capital raise, Harmless Harvest on its capital raise, NorStar Shipping on its capital raise, IDOC on its sale to The Riverside Company, Liberty Woods International on its sale to CoorsTek, Intersections Inc. on its private placement of a term loan to Crystal Financial, Infraredx Inc. on its sale to Nipro Corporation, Edgewood Management LLC on its internal equity plan and valuation, Elion Partners on its private equity fundraise and FallLine Group on its private equity fundraise.
He is an Advisory Board Member and on the Finance Committee of Mount Sinai Health Systems, a Board Member of NuLabel Technologies, a Board Member of FallLine Group, and an Advisor to the Board of Synexis Biodefense Systems. Mr. Kempner is a Trustee of the James Loring Johnson 1944 Trust and a Trustee for an American artist and sculptor. Mr. Kempner received a B.A. from Yale University and an M.B.A. from Harvard Business School.